AgNPs	Silver nanoparticles;
AIT	Autoimmune thyroiditis;
AKT	Protein kinase B;
ALDH	Aldehyde dehydrogenase;
ALK	Anaplastic lymphoma kinase;
Anti-Tg	Antithyroglobulin;
ART	Artesunate;
ATC	Anaplastic thyroid carcinoma;
ATD	Anti-thyroid drugs;
BMI	Body mass index;
BRAF	B-Raf proto-oncogene, serine/threonine kinase;
BRSK2	Brain-selective Kinase 2;
Cd	Cadmium;
CD4	Cluster of differentiation 4;
CDK1	Cyclin-dependent kinase 1
CLNM	Central lymph nodes;
Co	Cobalt;
CSCs	Cancer stem cells;
CT	Computed tomography;
Cu	Copper;
CXCL10	CXC motif 10 chemokine;
CXCL14	C-X-C motif chemokine ligand 14;
CXCL8	CXC motif chemokine ligand 8;
DAPK1	Death-associated protein kinase 1;
DICER1	Dicer 1 ribonuclease III;
DIOs	Deiodinases;
Dit	Diiodothyronine;
DMPS	2,3-dimercaptopropane-1-sulfonate;
DSF	Disulfiram;
DTC	Differentiated thyroid carcinoma;
DTCs	Differentiated thyroid carcinomas;
DUOX2	Dual oxidase 2;
EBRT	External beam radiotherapy;
EDTA	Ethylenediaminetetraacetic acid;
ERK	Extracellular signal-regulated kinase;
ES	Esclomol;
FDX1	Ferredoxin-1;
Fe	Iron;
Foxp3	Forkhead/winged helix transcription factor p3;
FT3	Free forms of triiodothyronine;
FT4	Free forms of thyroxine;
FTC	Follicular thyroid cancer;
GO	Graves’ ophthalmopathy;
GPER	G protein-coupled estrogen receptor;
GPX4	Glutathione peroxidase 4;
GSH-Px	Glutathione peroxidise;
Hb	Hemoglobin;
HER3	Human epidermal growth factor receptor-3;
Hg	Mercury;
HIF-1α	Hypoxia-inducible factor 1 alpha;
HLA-DPB1	Major histocompatibility complex, class II, DP beta 1;
HO-1	Heme oxygenase-1;
HPT	Hypothalamus–pituitary–thyroid axis;
hs-CRP	High-sensitivity C-reactive protein;
I	Iodine;
ICAM1	Intercellular adhesion molecule 1;
ICM	Iodine contrast media;
IFNα	Interferon-α;
IgE	Immunoglobulin E;
IIH	Iodine-induced hyperthyroidism;
IL	Interleukin;
INFγ	Interferon-γ;
ING4	Inhibitor of growth 4;
IRF-4	Interferon regulatory factor 4;
ITGA6	Integrin subunit alpha 6;
JBP	Iodine-based phenomenon;
Keap1	Kelch-like ECH-associated protein 1;
LC3-II	1A/1B-light chain 3—phosphatidylethanolamine conjugate;
LC-AgNPs	Silver nanoparticles from Livistona chinensis leaf extract;
MAPK	Mitogen-activated protein kinase;
MCP-1	Monocyte chemoattractant protein-1;
MCT10	Monocarboxylate transporter 10;
MCT8	Monocarboxylate transporter 8;
MeHg	Methylmercury;
MEK1/2	Mitogen-activated protein kinase;
Mir19A	MicroRNA 19a;
Mit	Monoiodothyronine;
MMPs	Matrix metalloproteins;
Mn	Manganese;
MONPs	Metal oxide nanoparticles;
MRI	Magnetic resonance imaging;
mRNA	Micro-RNA;
MT	Metallothioneins;
MTC	Medullary thyroid carcinoma;
MTH1	Targeting MutT homolog 1;
mTOR	Mammalian target of rapamycin;
MVD	Microvessel density;
NaI	Sodium iodide;
NDRG1	N-myc downstream regulated 1;
NF-κB	Nuclear factor kappa-light-chain-enhancer of activated B cells;
NICU	Neonatal intensive care unit;
NIS	Sodium/iodide symporter;
NKX2 1	NK2 homeobox 1;
NLRP3	Nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3;
Notch	Neurogenic locus notch homolog protein;
Nrf2	Nuclear factor erythroid 2–related factor 2;
NSAIDs	Non-steroidal anti-inflammatory drugs;
OR4K17	Olfactory receptor family 4 subfamily K member 17;
PAX-8	Paired box gene 8;
Pb	Lead;
PDCD1LG2	Programmed cell death 1 ligand 2;
PI3K	Phosphatidylinositol 3-kinase;
PRKAA2	Protein kinase AMP-activated catalytic subunit alpha 2;
Ps-AgNPs	P. aeruginosa synthesized AgNPs;
PTC	Papillary thyroid cancer;
PU.1	Transcription factor PU.1;
RAB8A	Ras-related protein Rab-8A;
RAI	Radioactive iodine;
RAIR	Radioiodine refractory;
RAIR-DTC	Iodine-refractory differentiated thyroid cancer;
RAP1A	Ras-related protein Rap-1A;
RAS	Rat sarcoma virus;
RET	Rearranged during transfection;
RORα	Retinoid-related orphan receptor alpha;
RORγt	Retinoic acid-related orphan receptor gamma t;
ROS	Reactive oxygen species;
rT3	Reverse triiodothyronine;
RTHβ	Resistance to thyroid hormone β;
SCD	Systemic contact dermatitis;
Se	Selenium;
SF	Serum ferritin;
SLC5A5	Solute carrier family 5 member 5;
SOD	Superoxide dismutase;
SPANXA1	Sperm protein associated with the nucleus, X-linked, family member A1;
SPECT	Single photon emission computed tomography;
STAT3	Signal transducer and activator of transcription 3;
sTg	Stimulated thyroglobulin;
T2	3,3′-diiodo-L-thyronine;
T3	Triiodothyronine;
T4	Thyroxine;
TBG	Thyroxine-binding globulin;
TC	Total cholesterol;
TERT	Telomerase reverse transcriptase;
Tg	Thyroglobulin;
TG	Triglyceride;
TgAb	Autoantibodies against thyroglobulin;
TGF-β	transforming growth factor β;
TH	Thyroid hormones;
THA	Total hip arthroplasty;
THCA	Tetrahydrocannabinolic acid;
TIMPs	Tissue inhibitors of matrix metalloproteinases;
TM	Tetrathiomolybdate;
TNF-α	Tumor necrosis factor-alpha;
TNFAIP8	Tumor necrosis factor alpha-induced protein 8;
TP53	Tumor protein p53;
TPO	Thyroperoxidase;
TPOAb	Autoantibodies against thyroid peroxidise;
Treg	Regulatory T cells;
TRH	Thyrotropin-releasing hormone;
TSH	Thyroid-stimulating hormone;
TSHoma	Thyrotropin-secreting adenoma;
TSHR	Thyrotropin receptor;
TTR	Transthyretin;
UIC	Urinary iodine concentration;
UIE	Urinary iodine excretion;
UPS10	Ubiquitin-specific peptidase 10;
USI	Universal salt iodization;
UTC	Undifferentiated thyroid cancer;
VEGF-A	Vascular endothelial growth factor;
WCE	Wolff–Chaikoff effect;
XBP1	X-box binding protein 1;
YWHAG	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase;
ZHX2	Zinc fingers homeoboxes;
Zn	Zinc;
ZNF703	Zn finger protein;